SAN FRANCISCO, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- The National Psoriasis Foundation (NPF) is ...

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...

Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...

Learn about psoriasis treatment costs, from affordable steroids to costly biologics.

Between 20 and 30 percent of people with psoriasis eventually develop a second, more disabling problem: painful joint inflammation. Known as psoriatic arthritis, it can quietly worsen and, without ...

The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity ...

Assessing disease severity in younger patients remains complex because adult scoring tools may underestimate the disease ...

Approximately 20% to 30% of all people who suffer from psoriasis also develop painful inflammation in their joints over time. If left untreated, this condition known as psoriatic arthritis can lead to ...

An Evening of Jazz & Generosity Returns to Atlanta ATLANTA, GA, UNITED STATES, January 20, 2026 /EINPresswire.com/ ...

Taiwan: Patients with psoriasis face a significantly higher risk of developing anti-neutrophil cytoplasmic antibody ...

Learn to communicate confidently about the condition, manage self-consciousness, and define yourself beyond your skin for ...